Matches in SemOpenAlex for { <https://semopenalex.org/work/W4220938102> ?p ?o ?g. }
- W4220938102 endingPage "439" @default.
- W4220938102 startingPage "431" @default.
- W4220938102 abstract "Rationale: The “Berlin definition” of acute respiratory distress syndrome (ARDS) does not allow inclusion of patients receiving high-flow nasal oxygen (HFNO). However, several articles have proposed that criteria for defining ARDS should be broadened to allow inclusion of patients receiving HFNO. Objectives: To compare the proportion of patients fulfilling ARDS criteria during HFNO and soon after intubation, and 28-day mortality between patients treated exclusively with HFNO and patients transitioned from HFNO to invasive mechanical ventilation (IMV). Methods: From previously published studies, we analyzed patients with coronavirus disease (COVID-19) who had PaO2/FiO2 of ⩽300 while treated with ⩾40 L/min HFNO, or noninvasive ventilation (NIV) with positive end-expiratory pressure of ⩾5 cm H2O (comparator). In patients transitioned from HFNO/NIV to invasive mechanical ventilation (IMV), we compared ARDS severity during HFNO/NIV and soon after IMV. We compared 28-day mortality in patients treated exclusively with HFNO/NIV versus patients transitioned to IMV. Measurements and Main Results: We analyzed 184 and 131 patients receiving HFNO or NIV, respectively. A total of 112 HFNO and 69 NIV patients transitioned to IMV. Of those, 104 (92.9%) patients on HFNO and 66 (95.7%) on NIV continued to have PaO2/FiO2 ⩽300 under IMV. Twenty-eight-day mortality in patients who remained on HFNO was 4.2% (3/72), whereas in patients transitioned from HFNO to IMV, it was 28.6% (32/112) (P < 0.001). Twenty-eight-day mortality in patients who remained on NIV was 1.6% (1/62), whereas in patients who transitioned from NIV to IMV, it was 44.9% (31/69) (P < 0.001). Overall mortality was 19.0% (35/184) and 24.4% (32/131) for HFNO and NIV, respectively (P = 0.2479). Conclusions: Broadening the ARDS definition to include patients on HFNO with PaO2/FiO2 ⩽300 may identify patients at earlier stages of disease but with lower mortality." @default.
- W4220938102 created "2022-04-03" @default.
- W4220938102 creator A5006917212 @default.
- W4220938102 creator A5021770480 @default.
- W4220938102 creator A5023434159 @default.
- W4220938102 creator A5027371207 @default.
- W4220938102 creator A5030193021 @default.
- W4220938102 creator A5030961669 @default.
- W4220938102 creator A5035629843 @default.
- W4220938102 creator A5035850499 @default.
- W4220938102 creator A5038157846 @default.
- W4220938102 creator A5038178496 @default.
- W4220938102 creator A5040201206 @default.
- W4220938102 creator A5041519561 @default.
- W4220938102 creator A5048619629 @default.
- W4220938102 creator A5052155859 @default.
- W4220938102 creator A5068430114 @default.
- W4220938102 creator A5087210763 @default.
- W4220938102 creator A5089262043 @default.
- W4220938102 creator A5091791900 @default.
- W4220938102 date "2022-02-15" @default.
- W4220938102 modified "2023-10-16" @default.
- W4220938102 title "High-Flow Nasal Oxygen for Severe Hypoxemia: Oxygenation Response and Outcome in Patients with COVID-19" @default.
- W4220938102 cites W1803784511 @default.
- W4220938102 cites W1981911503 @default.
- W4220938102 cites W2031326228 @default.
- W4220938102 cites W2032322221 @default.
- W4220938102 cites W2037459166 @default.
- W4220938102 cites W2062549383 @default.
- W4220938102 cites W2080328983 @default.
- W4220938102 cites W2112464900 @default.
- W4220938102 cites W2148218430 @default.
- W4220938102 cites W2169732472 @default.
- W4220938102 cites W2206411056 @default.
- W4220938102 cites W2248334179 @default.
- W4220938102 cites W2296109081 @default.
- W4220938102 cites W2297491622 @default.
- W4220938102 cites W2317838583 @default.
- W4220938102 cites W2325759523 @default.
- W4220938102 cites W2536303762 @default.
- W4220938102 cites W2589709778 @default.
- W4220938102 cites W2597070792 @default.
- W4220938102 cites W2611276332 @default.
- W4220938102 cites W2620241325 @default.
- W4220938102 cites W2775885085 @default.
- W4220938102 cites W2784899832 @default.
- W4220938102 cites W3046804999 @default.
- W4220938102 cites W3048002501 @default.
- W4220938102 cites W3089710067 @default.
- W4220938102 cites W3091969201 @default.
- W4220938102 cites W3098648006 @default.
- W4220938102 cites W3119286311 @default.
- W4220938102 cites W3137551872 @default.
- W4220938102 cites W3154610160 @default.
- W4220938102 cites W3157191866 @default.
- W4220938102 cites W4237939525 @default.
- W4220938102 doi "https://doi.org/10.1164/rccm.202109-2163oc" @default.
- W4220938102 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34861135" @default.
- W4220938102 hasPublicationYear "2022" @default.
- W4220938102 type Work @default.
- W4220938102 citedByCount "27" @default.
- W4220938102 countsByYear W42209381022022 @default.
- W4220938102 countsByYear W42209381022023 @default.
- W4220938102 crossrefType "journal-article" @default.
- W4220938102 hasAuthorship W4220938102A5006917212 @default.
- W4220938102 hasAuthorship W4220938102A5021770480 @default.
- W4220938102 hasAuthorship W4220938102A5023434159 @default.
- W4220938102 hasAuthorship W4220938102A5027371207 @default.
- W4220938102 hasAuthorship W4220938102A5030193021 @default.
- W4220938102 hasAuthorship W4220938102A5030961669 @default.
- W4220938102 hasAuthorship W4220938102A5035629843 @default.
- W4220938102 hasAuthorship W4220938102A5035850499 @default.
- W4220938102 hasAuthorship W4220938102A5038157846 @default.
- W4220938102 hasAuthorship W4220938102A5038178496 @default.
- W4220938102 hasAuthorship W4220938102A5040201206 @default.
- W4220938102 hasAuthorship W4220938102A5041519561 @default.
- W4220938102 hasAuthorship W4220938102A5048619629 @default.
- W4220938102 hasAuthorship W4220938102A5052155859 @default.
- W4220938102 hasAuthorship W4220938102A5068430114 @default.
- W4220938102 hasAuthorship W4220938102A5087210763 @default.
- W4220938102 hasAuthorship W4220938102A5089262043 @default.
- W4220938102 hasAuthorship W4220938102A5091791900 @default.
- W4220938102 hasBestOaLocation W42209381021 @default.
- W4220938102 hasConcept C126322002 @default.
- W4220938102 hasConcept C127413603 @default.
- W4220938102 hasConcept C141983124 @default.
- W4220938102 hasConcept C200457457 @default.
- W4220938102 hasConcept C2776348555 @default.
- W4220938102 hasConcept C2776779939 @default.
- W4220938102 hasConcept C2777080012 @default.
- W4220938102 hasConcept C2777714996 @default.
- W4220938102 hasConcept C2778716859 @default.
- W4220938102 hasConcept C2779134260 @default.
- W4220938102 hasConcept C2909621147 @default.
- W4220938102 hasConcept C3007834351 @default.
- W4220938102 hasConcept C3008058167 @default.
- W4220938102 hasConcept C3019440749 @default.
- W4220938102 hasConcept C42219234 @default.